[4] [5] By targeting all three receptors, retatrutide is designed to produce significant reductions in body weight and improvements in glycaemic control, making it a candidate for treating obesity and type 2 diabetes
Patients should seek immediate medical attention for signs of possible complications such as cellulitis (redness, warmth, fever), deep vein thrombosis (sudden unilateral swelling, calf pain), or significant worsening of symptoms
Four-dose Mounjaro KwikPen approved by MHRA for diabetes and weight management
This means drug levels are consistent from injection to injection, and the effects become more predictable and stable
Most injectable GLP-1 medicationsincluding semaglutide (Wegovy) and tirzepatide (Zepbound)are given once a week
That broader mechanism is a big part of why so many researchers see it as a step beyond earlier single-pathway compounds